Aligning incentives to fulfil the promise of personalised medicine

The Promise and the Hype of ‘Personalised Medicine’

Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, has fallen below expectations because of the challenges of tumour heterogeneity and clonal evolution. In both benign and malignant disease, diseases caused by single genetic alterations are more amenable to precision medicine approaches. However, most...

Personalised Medicine and the Economy of Biotechnological Promise

Rather than seek to distinguish hype from legitimate promise, it may be more helpful to think about personalised medicine as embodying a promissory economy which serves both to mobilize resources for research and - partly at least - to determine the ends to which that research is directed. Personalised medicine is a development of the larger promissory economy of medical biotechnology. As such,...

DNA microarrays in breast cancer: the promise of personalised medicine.

COMMENTARY See page 1590 Breast cancer is clinically heterogeneous, with varying natural history and response to treatment. Despite much effort to identify clinical measures of risk, methods to accurately predict an individual's clinical course are lacking. Whilst lymph-node status at diagnosis is the most important measure for future recurrence and overall survival, it is a surrogate that is i...

the evaluation and comparison of two esp textbooks available on the iranian market for teaching english to the students of medicine

abstract this study evaluated and compared medical terminology and english for the students of medicine (ii) as two representatives of the textbooks available on the iranian market for teaching english to the students of medicine. this research was performed on the basis of a teacher’s and a number of students’ attitudes and the students’ needs analysis for two reasons: first, to investigate...

Aligning Incentives in Medicare